Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KMS MedisurgiBOM:540468 79 EBIT per Share is ₹1.31 as of Mar. 2026. GuruFocus rates BOM:540468 with a GF Score™ of 79/100 and a GF Value™ of ₹111.50 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 687 Medical Devices & Instruments companies, KMS Medisurgi ranks worse than 79.33% on this metric.
KMS Medisurgi's EBIT per Share for the
six
months ended in Mar. 2026 was ₹0.24.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹1.31.
During the past 12 months, the average EBIT per Share Growth Rate of KMS Medisurgi was -36.00% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -15.00% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 21.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for KMS Medisurgi's EBIT per Share or its related term are showing as below:
BOM:540468'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -60.5 Med: 29.85 Max: 166.8
Current: -15
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of KMS Medisurgi was 166.80% per year. The lowest was -60.50% per year. And the median was 29.85% per year.
BOM:540468's 3-Year EBIT Growth Rate is ranked worse than 79.33% of 687
companies
in the Medical Devices & Instruments industry
Industry Median: 9.1
vs BOM:540468: -15.00
KMS Medisurgi's EBIT for the
six
months ended in Mar. 2026 was ₹0.8 Mil.
KMS Medisurgi (BOM:540468) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
KMS Medisurgi EBIT per Share Related Terms
KMS Medisurgi EBIT per Share Historical Data
* Premium members only.
The historical data trend for KMS Medisurgi's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹1.31
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KMS Medisurgi (BOM:540468) has a EBIT per Share of ₹1.31 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on KMS Medisurgi and its competitors. According to the industry distribution chart, KMS Medisurgi ranks #545 out of 687 companies in the Medical Devices & Instruments industry, placing it in the top 79.3%.
Is KMS Medisurgi's EBIT per Share too high?
KMS Medisurgi's current EBIT per Share is ₹1.31. Based on the distribution chart, KMS Medisurgi ranks #545 out of 687 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, KMS Medisurgi has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does KMS Medisurgi's EBIT per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, KMS Medisurgi ranks #545 out of 687 companies for EBIT per Share. This places KMS Medisurgi in the lower half of its industry. The industry median EBIT per Share is 9.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.10, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on KMS Medisurgi and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KMS Medisurgi's current EBIT per Share is ₹1.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KMS Medisurgi stock overvalued right now?
Based on GuruFocus' analysis, KMS Medisurgi (BOM:540468) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹111.50, compared to a current price of ₹132.80 — trading 19.1% above its estimated fair value. The current EBIT per Share is ₹1.31. KMS Medisurgi's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For KMS Medisurgi (BOM:540468), the current EBIT per Share is ₹1.31 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KMS Medisurgi (BOM:540468) Overvalued in 2026?
Based on GuruFocus' analysis, KMS Medisurgi stock appears to be overvalued.
The current stock price of ₹132.80 is trading 19.1% above its estimated GF Value™ of ₹111.50.
GuruFocus considers KMS Medisurgi to be Modestly Overvalued.
Key valuation signals for BOM:540468:
EBIT per Share: ₹1.31
GF Value™: ₹111.50 vs. price of ₹132.80 (19.1% above fair value)
No single metric tells the full story. See the BOM:540468 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KMS Medisurgi Ltd manufactures surgical tapes and dressings for hospitals, institutions, trade associations, exporters, and importers. The company manufactures and undertakes job work of various substartes like non-woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive. The company's international presence includes Vietnam, Dubai, Europe, Australia, Cambodia, India, Africa, Philippines, Russia, Pakistan, Bangladesh, and the USA. The company derives revenue from the sale of goods.
79GF Score
Get the complete analysis for BOM:540468
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540468 has been successfully added to your 
